2735803-90-2
Chemical Structure
Sironestrant
Synonym(s): Estrogen receptor antagonist 2
- CAS. Nr.: 2735803-90-2
- Formula:C26H31F4N5
- Molecular Weight:489.55
IUPAC Name: (R)-3-(3-fluoro-4-(6-(2-(methyl-13C-d3)-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
InChIKey: GRCKMGXTYAMEJC-VDABOFBKSA-N
SMILES: C[C@@H]1CC2=C([C@H](N1CC(F)(F)F)C3=NC=C(C=C3)N[C@H]4CCN(C4)CCCF)NC5=CC=CC=C52
Biological Activity: Sironestrant (Estrogen receptor antagonist 2) (compound 3) is a selective estrogen receptor downregulator. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Sironestrant has the potential for the research of breast cancer diseases (extracted from patent WO2021228210A1, compound 3)[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sironestrant | Sironestrant (Estrogen receptor antagonist 2) (compound 3) is a selective estrogen receptor downregulator. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Sironestrant has the potential for the research of breast cancer diseases (extracted from patent WO2021228210A1, compound 3). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
